THE first clinically proven, non-surgical injectable treatment for improvement in the appearance of submental fullness (pictured), Belkyra (deoxycholic acid) has now been included on the Australian Register of Therapeutic Goods (ARTG).
The new double-chin therapy breaks down fat cells under the chin offering individually tailored and contoured chin profile, manufacturer Allergan said.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 May 17